-
A coalition of state attorneys general is suing the Food and Drug Administration over its regulation of mifepristone. NPR's Michel Martin speaks with Washington state Attorney General Bob Ferguson.
-
The at-home nasal swab kit simultaneously tests for COVID-19 and two strains of the flu.
-
The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.
-
Food and Drug Administration officials have issued guidance that says plant-based beverages don't pretend to be from dairy animals – and that U.S. consumers aren't confused by the difference.
-
The U.S. Food and Drug Administration announced last month that it will not apply dietary supplement regulations to the hemp product CBD. The announcement has been frustrating for hemp farmers who have been waiting years for regulation.
-
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.
-
Toxic metal can be harmful to developing brains. New lead targets are part of a broad FDA imitative to reduce children's exposure to the lowest levels possible.
-
The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.
-
In a victory for animal rights advocates, drugmakers can take their products to human clinical trials using alternative testing methods that don't involve animals.
-
The FDA has confirmed the nation is experiencing a shortage of Adderall after many pharmacies around the country have been unable to fill prescriptions and keep up with demand.